Jan 12, 2021 / 02:10PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Great. Good morning everyone. My name is Jess Fye. I am one of the senior biotech analysts at JPMorgan and we are continuing the 2021 Healthcare Conference this morning with Intra-Cellular. I'm joined by the company's CEO, Sharon Mates.
And before we get started, just wanted to remind you all that instead of moving to a breakout room this year, you'll be able to ask questions by clicking the blue 'Ask a Question' button on your screen that sends the questions to a portal. So I can ask them to management once we move into Q&A.
But with that out of the way, let me turn it over to Sharon.
Sharon Mates - Intra-Cellular Therapies, Inc. - Co-Founder, Chairman, CEO & President
Great. Thanks so much, Jess. It's a pleasure to be here. And I'm joined today by Mark Neumann, our Chief Commercial Officer; and Juan Sanchez, our Head of Investor Relations. So I'm going to go through the presentation, and I understand you all have access to it, and I'll try to remember to call
Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers